Results: 1-25 | 26-38
Results: 1-25/38

Authors: Arase, Y Chayama, K Ikeda, K Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Suzuki, F Akuta, N Someya, T Kobayashi, M Kumada, H
Citation: Y. Arase et al., Randomized controlled clinical trial of lymphoblastoid interferon-alpha for chronic hepatitis C, HEPATOL RES, 21(1), 2001, pp. 55-66

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration, HEPATOL RES, 19(1), 2001, pp. 22-30

Authors: Murashima, N Ikeda, K Kobayashi, M Saitoh, S Chayama, K Tsubota, A Suzuki, Y Suzuki, F Arase, Y Kumada, H
Citation: N. Murashima et al., Incidence of the appearance of the red color sign on esophageal varices and its predictive factors: long-term observations of 359 patients with cirrhosis, J GASTRO, 36(6), 2001, pp. 368-374

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen, J GASTRO, 36(4), 2001, pp. 242-247

Authors: Someya, T Suzuki, Y Arase, Y Kobayashi, M Suzuki, F Tsubota, A Saitoh, S Chayama, K Murashima, N Ikeda, K Kumada, H
Citation: T. Someya et al., Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant, J GASTRO, 36(2), 2001, pp. 133-136

Authors: Suzuki, F Chayama, K Tsubota, A Akuta, N Someya, T Kobayashi, M Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: F. Suzuki et al., Pathogenic significance and organic virus levels in patients infected withTT virus, INTERVIROLO, 44(5), 2001, pp. 291-297

Authors: Chayama, K Suzuki, F Tsubota, A Akuta, N Someya, T Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Ikeda, K Kumada, H
Citation: K. Chayama et al., Evaluation of quantitative measurements of hepatitis C virus RNA to predict sustained response to interferon by genotype, J VIROL MET, 95(1-2), 2001, pp. 33-45

Authors: Tsubota, AK Arase, Y Ren, FR Tanaka, H Ikeda, K Kumada, H
Citation: Ak. Tsubota et al., Genotype may correlate with liver carcinogenesis and tumor characteristicsin cirrhotic patients infected with hepatitis B virus subtype adw, J MED VIROL, 65(2), 2001, pp. 257-265

Authors: Akuta, N Chayama, K Suzuki, F Someya, T Kobayashi, M Tsubota, A Suzuki, Y Saitoh, S Arase, Y Ikeda, K Kumada, H
Citation: N. Akuta et al., Risk factors of hepatitis C virus-related liver cirrhosis in young adults:Positive family history of liver disease and transporter associated with antigen processing 2 (TAP2)0201 allele, J MED VIROL, 64(2), 2001, pp. 109-116

Authors: Nomura, J Arase, Y Sugita, T Sugaya, S Takahashi, S Kita, K Yamamori, H Sekiya, S Suzuki, N
Citation: J. Nomura et al., Increased and decreased expression of CD69 and CD23, respectively, in gravity-stressed lymphocytes, AVIAT SP EN, 72(8), 2001, pp. 727-732

Authors: Sudo, H Takahashi, Y Tonegawa, A Arase, Y Aoyama, H Mizutani-Koseki, Y Moriya, H Wilting, J Christ, B Koseki, H
Citation: H. Sudo et al., Inductive signals from the somatopleure mediated by bone morphogenetic proteins are essential for the formation of the sternal component of avian ribs, DEVELOP BIO, 232(2), 2001, pp. 284-300

Authors: Tsubota, A Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Chayama, K Murashima, N Ikeda, K Kobayashi, M Kumada, H
Citation: A. Tsubota et al., Lamivudine therapy for spontaneously occurring severe acute exacerbation in chronic hepatitis B virus infection: A preliminary study, AM J GASTRO, 96(2), 2001, pp. 557-562

Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Tsubota, A Suzuki, F Arase, Y Murashima, N Chayama, K Kumada, H
Citation: K. Ikeda et al., Distinction between chronic hepatitis and liver cirrhosis in patients withhepatitis C virus infection. Practical discriminant function using common laboratory data, HEPATOL RES, 18(3), 2000, pp. 252-266

Authors: Hiwasa, T Arase, Y Kikuno, K Hasegawa, R Sugaya, S Kita, K Saido, T Yamamori, H Maki, M Suzuki, N
Citation: T. Hiwasa et al., Increase in ultraviolet sensitivity by overexpression of calpastatin in ultraviolet-resistant UVr-1 cells derived from ultraviolet-sensitive human RSa cells, CELL DEAT D, 7(6), 2000, pp. 531-537

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course, J GASTRO, 35(8), 2000, pp. 607-612

Authors: Ikeda, K Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Arase, Y Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma, J GASTRO, 35(5), 2000, pp. 353-360

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Suzuki, F Kumada, H
Citation: Y. Arase et al., Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C, J GASTRO, 35(3), 2000, pp. 221-225

Authors: Kobayashi, M Chayama, K Arase, Y Tsubota, A Saitoh, S Suzuki, Y Kobayashi, M Murashima, N Ikeda, K Hagiwara, M Hashimoto, R Nakagawa, M Matsuda, M Kumada, H
Citation: M. Kobayashi et al., Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance, J GASTRO, 35(10), 2000, pp. 753-757

Authors: Kobayashi, M Ikeda, K Akuta, N Someya, T Suzuki, F Tsubota, A Suzuki, Y Saitoh, S Arase, Y Chayama, K Kumada, H
Citation: M. Kobayashi et al., Relationship between five-year histological outcome and serial changes in serum alanine aminotransferase in patients with biochemical and virologicalrelapse after interferon treatment for chronic hepatitis C, INTERVIROLO, 43(3), 2000, pp. 174-179

Authors: Chayama, K Suzuki, F Tsubota, A Kobayashi, M Arase, Y Saitoh, S Suzuki, Y Murashima, N Ikeda, K Takahashi, N Kinoshita, M Kumada, H
Citation: K. Chayama et al., Association of amino acid sequence in the PKR-eIF2 phosphorylation homology domain and response to interferon therapy, HEPATOLOGY, 32(5), 2000, pp. 1138-1144

Authors: Ikeda, K Arase, Y Saitoh, S Kobayashi, M Suzuki, Y Suzuki, F Tsubota, A Chayama, K Murashima, N Kumada, H
Citation: K. Ikeda et al., Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer, HEPATOLOGY, 32(2), 2000, pp. 228-232

Authors: Kobayashi, M Ikeda, K Saitoh, S Suzuki, F Tsubota, A Suzuki, Y Arase, Y Murashima, N Chayama, K Kumada, H
Citation: M. Kobayashi et al., Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, CANCER, 88(11), 2000, pp. 2471-2477

Authors: Arase, Y Hiwasa, T Hasegawa, R Nomura, J Ito, H Suzuki, N
Citation: Y. Arase et al., Prevention of v-Ha-ras-dependent apoptosis by PDGF coordinates in phosphorylation of ERK and Akt, BIOC BIOP R, 267(1), 2000, pp. 33-39

Authors: Tsubota, A Kumada, H Arase, Y Chayama, K Saitoh, S Ikeda, K Kobayashi, M Suzuki, Y Murashima, N
Citation: A. Tsubota et al., Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients, EUR J GASTR, 11(10), 1999, pp. 1077-1083

Authors: Arase, Y Ikeda, K Chayama, K Murashima, N Tsubota, A Nakamura, I Suzuki, Y Saitoh, S Kobayashi, M Kobayashi, M Kobayashi, M Kumada, H
Citation: Y. Arase et al., Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy, J GASTRO, 34(5), 1999, pp. 594-599
Risultati: 1-25 | 26-38